Clinical relationship between the mdrl gene and gallbladder cancer

王百林,翟淑萍,陈孝平

DOI: https://doi.org/10.3760/j.issn:1001-9030.2002.05.009

2002-01-01

Abstract:Objective To study expression of multidrug resistance l (mdrl) gene encoding P glycoprotein (Pgp) and mdrlmRNA in primary gallbladder carcinoma, analyze its clinical significance.Methods By using immunohistochemistry (IHC) S P method and in situ ploymerase chain reaction (ISPCR), the expression of Pgp and mdrlmRNA was detected in 53 cases of previously untreated primary gallbladder carcinoma and 12 cases of cholecystitis archival paraffin embedded tissues.Results The positive expression rate of Pgp and mdrlmRNA in 53 cases of gallbladder carcinoma and 12 cases of cholecystitis was 60.38%, 71.69% and 25.00%, 33.33% respectively. There was significant difference between the two groups (P0.05). The positive expression rate of Pgp and mdrlmRNA were 69.44%, 41.18%; 69.23%, 35.71%; 83.33%, 47.06% and 79.49%, 50.00% respectively in stage of Nevin Ⅰ Ⅲ in gallbladder carcinoma and histologic grading in good, moderate differentiation against that of NevinⅣ, Ⅴand low, undifferentiation. There was significant difterence between them (P0.05).Conclusion Multidrug resistance (MDR) in gallbladder carcinoma is closely related to the intrinic MDR and it provides an important evidence to reverse MDR by detection of mdrlgene. Meanwhile, mdrlgene expression in gallbladder carcinoma correlates with some biological characteristics, may take part in the carcinogenesis of gallbladder tissues and be used as an independent valuable biomarker of prognosis.